Scancell (LON:SCLP) Shares Cross Below Two Hundred Day Moving Average of $11.89

Scancell Holdings plc (LON:SCLPGet Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 11.89 ($0.15) and traded as low as GBX 10.50 ($0.13). Scancell shares last traded at GBX 10.75 ($0.14), with a volume of 58,810 shares traded.

Scancell Trading Down 2.3 %

The company has a 50-day moving average price of GBX 11 and a 200-day moving average price of GBX 11.89. The firm has a market capitalization of £97.42 million, a price-to-earnings ratio of -1,050.00 and a beta of 0.35. The company has a debt-to-equity ratio of 61.41, a quick ratio of 13.01 and a current ratio of 8.63.

Scancell Company Profile

(Get Free Report)

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer.

See Also

Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.